Skip to main content

Table 5 Sample analysis (n = 3)

From: Effective separation and simultaneous analysis of anabolic androgenic steroids (AAS) in their pharmaceutical formulations by a validated TLC-densitometry method

Brand name (sample code)

Compounds detected

Label claim (mg/injection)

Amount detected (mg/injection)

(Mean ± S.D.)

% R.S.D.

% Rec.

Testolic (S-1)

TP

100

96.4 ± 0.53

0.56

96.4

Sustanon 250 (S-2)

TP

30

27.15 ± 0.26

0.98

90.5

TPP

60

67.61 ± 0.41

0.62

112.6

TI

60

82.16 ± 0.55

0.68

136.9

TD

100

131.75 ± 1.97

1.50

131.7